Device for multiple complex immunoassays gets funding

Diagnostics firm Biosensia has secured funding to develop its RapiPlex point-of-care platform.

The prototype device is able to perform multiple different complex immunoassays — normally only possible by a trained technician in the lab — by nurses or general practitioners.

‘We’re trying to decentralise some of that testing out into the community,’ Diarmuid Flavin, Biosensia’s chief executive, told The Engineer.

Although there are similar diagnostic devices in development, RapiPlex uses a novel two-element design. First, an injection-moulded fluidic cartridge with multiple channels for different biomarkers is loaded with patient samples, whether blood, urine or saliva. The cartridge is then placed in a bench-top cradle that uses fluorescence excitation and detection to get a read-out.

‘The instrument is universal. We designed that flexibility into the system because a doctor’s office really just wants one box — one instrument on which you can do all assays of different varieties across different panels,’ Flavin said.

Crucially, the cartridge can be adapted to any particular suite of biomarkers up to a maximum of 12 and is then thrown away after use.

Register now to continue reading

Thanks for visiting The Engineer. You’ve now reached your monthly limit of news stories. Register for free to unlock unlimited access to all of our news coverage, as well as premium content including opinion, in-depth features and special reports.  

Benefits of registering

  • In-depth insights and coverage of key emerging trends

  • Unrestricted access to special reports throughout the year

  • Daily technology news delivered straight to your inbox